Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Comments

Aura Biosciences Inc Earnings Estimates

AURANASDAQ

Trade with Public

$5.67

Last update: Mar 9, 4:00 PM

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Aura Biosciences (AURA) is scheduled to report Q4 earnings on March 23, 2026. Analysts estimate EPS of $-0.43 and quarterly revenue of N/A.

In the most recent quarter (Q3), Aura Biosciences reported EPS of $-0.40, beating estimates of $-0.46 by 0.13%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Aura Biosciences has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Aura Biosciences has averaged an EPS surprise of 0.11% and a revenue surprise of 0.00%.

Earnings Date

Mar 23

EPS Estimate

$-0.430

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–

Aura Biosciences Earnings History

Analyze the earnings history of Aura Biosciences using advanced sorting and filters.

Aura Biosciences (AURA) Earnings Per Share

The chart below shows Aura Biosciences's reported EPS compared to analyst estimates over recent quarters.

Aura Biosciences (AURA) Revenue

The chart below shows Aura Biosciences's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Aura Biosciences (NASDAQ:AURA) reporting earnings?

Aura Biosciences (AURA) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on November 13, 2025 for Q3.

What were the latest earnings per share (EPS) for Aura Biosciences (NASDAQ:AURA)?

The Actual EPS was $-0.40, which beat the estimate of $-0.46.

What were Aura Biosciences’s (NASDAQ:AURA) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Monopar Therapeutics Inc

Bicycle Therapeutics PLC

Crescent Biopharma Inc

NASDAQ:CBIO

$12.53

4.24%

Greenwich LifeSciences Inc

NASDAQ:GLSI

$26.01

7.73%

Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Aura Biosciences (AURA) is scheduled to report Q4 earnings on March 23, 2026. Analysts estimate EPS of $-0.43 and quarterly revenue of N/A.

In the most recent quarter (Q3), Aura Biosciences reported EPS of $-0.40, beating estimates of $-0.46 by 0.13%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Aura Biosciences has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Aura Biosciences has averaged an EPS surprise of 0.11% and a revenue surprise of 0.00%.

Earnings Date

Mar 23

EPS Estimate

$-0.430

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–